Advertisement
Screener

ZIMMER BIOMET HOLDINGS, INC. (ZBH) ROI

ZIMMER BIOMET HOLDINGS, INC. ROI

Return on investment (ROI), also called return on invested capital, is the profit a company earns for every dollar of long-term capital from both lenders and shareholders, shown as a percentage. It is net income divided by long-term debt plus shareholder equity, and the table shows both amounts. Because debt is included in the base, ROI does not rise just because a company replaces equity with borrowing, which sets it apart from ROE. Quarterly points divide the trailing four quarters of net income by the balance at that quarter end; annual points divide the filed fiscal-year net income by the fiscal-year-end balance.

  • ZIMMER BIOMET HOLDINGS, INC. roi for the quarter ending 2026-06-30 was 4.01%, a 2.06% decline year-over-year.
  • ZIMMER BIOMET HOLDINGS, INC. roi for the quarter ending 2026-03-31 was 3.78%, a 19.04% decline year-over-year.
  • ZIMMER BIOMET HOLDINGS, INC. roi for the quarter ending 2025-12-31 was 3.49%, a 27.95% decline year-over-year.
  • ZIMMER BIOMET HOLDINGS, INC. roi for the quarter ending 2025-09-30 was 3.86%, a 32.96% decline year-over-year.
  • ZIMMER BIOMET HOLDINGS, INC. roi for fiscal 2025 was 3.49%, a 27.94% decline from fiscal 2024.
  • ZIMMER BIOMET HOLDINGS, INC. roi for fiscal 2024 was 4.84%, a 13.75% decline from fiscal 2023.
  • ZIMMER BIOMET HOLDINGS, INC. roi for fiscal 2023 was 5.61%, a 329.62% increase from fiscal 2022.
  • ZIMMER BIOMET HOLDINGS, INC. roi for fiscal 2022 was 1.31%, a 35.84% decline from fiscal 2021.
Available history
2010-12-31 to 2026-06-30
Data captured

Historical ROI

DateROINet income 12 monthNet income 3 monthDebt plus equity
2026-06-304.01%$806.6M$198.30M$20.11B
2026-03-313.78%$761.1M$238.10M$20.15B
2025-12-313.49%$705M$139.30M$20.22B
2025-09-303.86%$805.2M$230.90M$20.88B
2025-06-304.10%$823.4M$152.80M$20.11B
2025-03-314.66%$913.4M$182.00M$19.58B
2024-12-314.84%$903.8M$239.50M$18.68B
2024-09-305.75%$1.08B$249.10M$18.83B
2024-06-305.37%$997.1M$242.80M$18.58B
2024-03-315.24%$963.9M$172.40M$18.4B
2023-12-315.61%$1.02B$419.20M$18.26B
2023-09-302.63%$474.3M$162.70M$18B
2023-06-302.80%$505.6M$209.60M$18.09B
2023-03-312.51%$449.7M$232.50M$17.95B
2022-12-311.31%$231.4M-$130.50M$17.72B
2022-09-301.55%$277.9M$194.00M$17.97B
2022-06-301.26%$229.5M$153.70M$18.15B
2022-03-311.19%$217.7M$14.20M$18.32B
2021-12-312.03%$401.6M-$84.00M$19.74B
2021-09-304.05%$819.3M$145.60M$20.22B
2021-06-304.48%$916.2M$141.90M$20.44B
2021-03-312.80%$567.7M$198.10M$20.29B
2020-12-31-0.68%-$138.9M$333.70M$20.33B
2020-09-30-0.75%-$151.9M$242.50M$20.17B
2020-06-300.18%$36.7M-$206.60M$19.85B
2020-03-311.75%$377M-$508.50M$21.56B
2019-12-315.49%$1.13B$320.70M$20.61B
2019-09-30-0.44%-$90.2M$431.10M$20.43B
2019-06-30-1.76%-$359.1M$133.70M$20.38B
2019-03-31-1.51%-$307.8M$246.10M$20.35B
2018-12-31-1.88%-$379.2M-$901.10M$20.21B
2018-09-308.19%$1.75B$162.20M$21.42B
2018-06-307.84%$1.69B$185.00M$21.56B
2018-03-317.31%$1.69B$174.70M$23.11B
2017-12-318.29%$1.81B$1.23B$21.88B
2017-09-303.12%$652M$98.80M$20.87B
2017-06-303.40%$712M$184.20M$20.96B
2017-03-312.32%$496.5M$299.40M$21.45B
2016-12-311.46%$305.9M$69.60M$20.91B
2016-09-301.70%$363.3M$158.80M$21.33B
2016-06-301.10%$226.7M-$31.30M$20.58B
2015-09-300.79%$173.8M$22.20M$21.91B
2015-06-301.46%$324.7M-$173.60M$22.17B
2013-12-319.78%$780.4M$235.90M$7.98B
2012-12-319.84%$755M$152.80M$7.67B
2012-09-3010.03%$758.8M$178.10M$7.57B
2012-06-3010.38%$772.2M$214.50M$7.44B
2012-03-3110.32%$761.5M$209.60M$7.38B
2011-12-3110.52%$760.8M$156.60M$7.23B
2010-12-318.63%$596.9M$34.90M$6.91B

Annual ROI

DateROINet income 12 monthDebt plus equity
2025-12-313.49%$705.1M$20.22B
2024-12-314.84%$903.8M$18.68B
2023-12-315.61%$1.02B$18.26B
2022-12-311.31%$231.4M$17.72B
2021-12-312.03%$401.6M$19.74B
2020-12-31-0.68%-$138.9M$20.33B
2019-12-315.49%$1.13B$20.61B
2018-12-31-1.88%-$379.2M$20.21B
2017-12-318.29%$1.81B$21.88B
2016-12-311.46%$305.9M$20.91B
2013-12-319.78%$780.4M$7.98B
2012-12-319.84%$755M$7.67B
2011-12-3110.52%$760.8M$7.23B
2010-12-318.63%$596.9M$6.91B

Similar stocks

Stock NameCountryMarket CapPE Ratio
STERIS plc (STE)Ireland$20.343B25.49
ALIGN TECHNOLOGY INC (ALGN)United States$10.346B29.06
MSA Safety Inc (MSA)United States$7.023B21.47
ESTABLISHMENT LABS HOLDINGS INC. (ESTA)$1.954B-65.76
Cadre Holdings, Inc. (CDRE)United States$1.123B33.88
Enovis CORP (ENOV)United States$1.053B-1.18
Anteris Technologies Global Corp. (AVR)United States$0.746B
Sanara MedTech Inc. (SMTI)United States$0.323B-6.81
Inogen Inc (INGN)United States$0.139B-7.00
Conexeu Sciences Inc. (CNXU)United States$0.111B